Treatment of Recurrent Non-Hodgkin's Lymphoma (NHL) With CHOP Regimen-Observation of the Short-term Curative Effect in 38 Cases
-
摘要: 本文报道CHOP方案治疗38例复发性非何杰金氏淋巴瘤(NHL)的结果,全部病例均经病理组织学证实。按成都会议方案属中、高度恶性者78.9%,Ⅲ、Ⅳ期病人占65.8%。均经CHOP方案化疗4~11疗程,6疗程以上者占71%,8例加用其它一些抗癌药,9例化疗后予以放疗或手术切除。全组总的缓解率71%,完全缓解率31%,中位缓解期10.3个月。主要毒副反应为消化道反应、白细胞减少及脱发,一般病人都可耐受。作者认为,CHOP方案是一个安全有效的化疗方案,可用于复发性NHL的治疗。Abstract: The results of chemotherapy with CHOP regimen in 38 recurrent patients of NHL, all pathologically confirmed, were reported. 78.9% of the cases were medi-an-grade or high-grade malignant lymphoma according to Chendo meet's classifica-tions schedule NHL conducted classification (1985), 65.8% of the cases at Ⅲ, Ⅳ stage. The therapy time for the patients treated by CHOP regimen were 4~11 courses, 70% of the cases over 6 courses. All patients were treated by CHOP regi-men,8 cases also applied the other anticarcinogenic drugs, and 9 cases underwent adjuvant radiotherapy or surgient therapy to the residual disease following chemotherapy. The result for the whole group, total response rate was 71%, com-pleted remission rate 31%, and MTS 10.3M. The main side effects including gas-trointestinal toxicity, leucopenia and alopecia were not serve . The authors believe that CHOP is a safe, effective regimen for the patients with relaped case of NHL.
-
Key words:
- CHOP regimen /
- Chemotherapy /
- Non-Hodgkin's lymphoma /
- Recurrent
-
-
[1] 黄雪珍, 毛雪芹, 吴晕, 等. ProMACE-MOPP方案治疗NHL(附56例分析). 实用肿瘤杂志, 1992, 7(3): 160. [2] 江伟, 祝浩强, 张一欧, 等. CHOP与BEPPA交替治疗进展型恶性淋巴瘤17例近期疗效观察. 癌症, 1991, 10(6): 511. [3] 管忠震, 喻俪华, 何友谦, 等. 用CHOP方案治疗NHL103例临床疗效及毒性观察. 癌症, 1989, 8(2): 98. [4] 刘淑真, 宋晓红, 杨蔚置, 等. CHOP方案治疗NHL近期疗效分析. 河南肿瘤学杂志, 1993, 6(4): 301. -
期刊类型引用(3)
1. 张梦瑶,张飞飞. ~(18)F-FDG PET/CT在弥漫大B细胞淋巴瘤中的研究进展. 内蒙古医学杂志. 2024(05): 600-604 . 百度学术
2. 林莉,文兴林,卢艳芳,陈华,廖娟彬,郭佳. ~(18)F-FDG PET-CT显像在原发结外淋巴瘤诊断中的应用体会. 当代医学. 2022(20): 175-177 . 百度学术
3. 秦芹,马超. ~(18)F-FDG PET/CT结合CD5表达对弥漫性大B细胞淋巴瘤的预后评估价值. 现代医用影像学. 2021(12): 2234-2238 . 百度学术
其他类型引用(1)
计量
- 文章访问数: 975
- HTML全文浏览量: 62
- PDF下载量: 404
- 被引次数: 4